Certified by Founder
Lodge
kyron.bio
start up
France
- Paris, Île-de-France
- 29/05/2025
- Unknown
- $6,202,354
Kyron.bio is revolutionising the way we make our therapeutic drugs.
Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective.
Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved by the pharmaceutical industry.
- Industry Biotechnology
- Website https://www.kyron.bio/
- LinkedIn https://www.linkedin.com/company/kyron-bio/
Surf AI(1) | $57,000,000 | (Mar 18, 2026)
Dark Watch | $3,500,000 | (Mar 17, 2026)
Gangkhar | $4,250,000 | (Mar 17, 2026)
Malama Health | $9,200,000 | (Mar 17, 2026)
Great Sky | $14,000,000 | (Mar 17, 2026)
Understood Care | $5,000,000 | (Mar 17, 2026)
AgZen | $10,000,000 | (Mar 17, 2026)
Certiv | $4,200,000 | (Mar 17, 2026)
Scanner | $22,000,000 | (Mar 17, 2026)
Zero RFI | $13,800,000 | (Mar 17, 2026)
Nadia Care | $12,000,000 | (Mar 17, 2026)
Eileen Inc. | $1,000,000 | (Mar 17, 2026)
Halcyon(US) | $21,000,000 | (Mar 17, 2026)